Clinimix E NDC 0338-1144

Product information

Brand name (proprietary)

Clinimix E

Generic name (nonproprietary)

leucine, phenylalanine, lysine, methionine, isoleucine, valine, histidine, threonine, tryptophan, alanine, glycine, arginine, proline, serine, tyrosine, sodium acetate, dibasic potassium phosphate, magnesium chloride, sodium chloride, calcium chloride, dextrose

Active ingredients

Leucine — 311 mg/100mLPhenylalanine — 238 mg/100mLLysine — 247 mg/100mLMethionine — 170 mg/100mLIsoleucine — 255 mg/100mLValine — 247 mg/100mLHistidine — 204 mg/100mLThreonine — 179 mg/100mLTryptophan — 77 mg/100mLAlanine — 880 mg/100mLGlycine — 438 mg/100mLArginine — 489 mg/100mLProline — 289 mg/100mLSerine — 213 mg/100mLTyrosine — 17 mg/100mLSodium acetate — 297 mg/100mLPotassium phosphate, Dibasic — 261 mg/100mLMagnesium chloride — 51 mg/100mLSodium chloride — 77 mg/100mLCalcium chloride — 33 mg/100mLDextrose — 5 g/100mL

Dosage form

Injection

Route

Intravenous

Labeler

Baxter Healthcare Company

Product type

Prescription drug

Marketing category

NDA — New Drug ApplicationApplication NDA 020678

Marketing start

Mar 26, 1997

Listing expires

Dec 31, 2027

Other FDA classes

Amino Acids (Chemical structure)Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)

Identifiers

Product ID 0338-1144_c5f1da6b-9b01-4814-97a5-3d7efbedec9cSPL ID c5f1da6b-9b01-4814-97a5-3d7efbedec9cSPL set ID 8469d6fb-d6ef-476f-8cc3-0905192de0a8RxCUI 800998, 801000, 801010, 801012, 801019, 801021, 801029, 801031, 1090635, 1090639UNII AE28F7PNPL, 4QD397987E, 04Y7590D77, 451W47IQ8X, 02F3473H9O, OF5P57N2ZX, TE7660XO1C, GMW67QNF9C, 8DUH1N11BX, 94ZLA3W45F, 47E5O17Y3R, 4550K0SC9B, IY9XDZ35W2, K3Z4F929H6, HG18B9YRS7, 42HK56048U, 452VLY9402, 2ZD004190S, M4I0D6VV5M, 9DLQ4CIU6V, CI71S98N1Z

Pharmacologic class

Amino Acid; Blood Coagulation Factor; Calculi Dissolution Agent; Osmotic Laxative; Phosphate Binder

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400338114403 followed by a unit qualifier and the quantity Copy

Package 00338-1144-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under NDA 020678

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

Showing 20 of 21.